Characterization of Burkholderia rhizoxinica and B. endofungorum from Clinical Specimens
Author Information
Author(s): Gee Jay E., Glass Mindy B., Lackner Gerald, Helsel Leta O., Daneshvar Maryam, Hollis Dannie G., Jordan Jean, Morey Roger, Steigerwalt Arnold, Hertweck Christian
Primary Institution: Centers for Disease Control and Prevention
Hypothesis
The study aims to identify and characterize clinical isolates of Burkholderia rhizoxinica and B. endofungorum.
Conclusion
The study successfully identified seven clinical isolates as B. rhizoxinica and one as B. endofungorum, demonstrating their potential role in human infections.
Supporting Evidence
- Eight clinical isolates were identified as members of the genus Burkholderia.
- Seven isolates were identified as B. rhizoxinica and one as B. endofungorum.
- The study assessed toxin production and characterized the isolates using multiple methods.
Takeaway
Scientists found bacteria in clinical samples that can make toxins, which might be important for understanding infections.
Methodology
The study used biochemical testing, 16S rRNA gene sequencing, and DNA-DNA hybridization to identify and characterize the isolates.
Limitations
Clinical records for the isolates were incomplete, and the possibility of contamination could not be excluded.
Participant Demographics
The isolates were derived from five adult males and three adult females.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website